The SARS CoV-2 spike directed non-neutralizing polyclonal antibodies cross-react with Human immunodeficiency virus (HIV-1) gp41

References

Page 1

	Year	Citations
Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody Dora Pinto, Young‐Jun Park, Martina Beltramello, Nature Vaccine TargetImmunologyAntibody EngineeringMedicineCovid-19	2020	2.1K
Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition Oliver C. Grant, David W. Montgomery, Keigo Ito, Scientific Reports	2020	407
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation Yasunori Watanabe, Zachary T. Berndsen, Jayna Raghwani, Nature Communications	2020	393
High prevalence of pre-existing serological cross-reactivity against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in sub-Saharan Africa For Yue Tso, Salum J. Lidenge, Phoebe B. Peña, International Journal of Infectious Diseases	2020	257
Epitope-resolved profiling of the SARS-CoV-2 antibody response identifies cross-reactivity with endemic human coronaviruses Jason T. Ladner, Sierra N. Henson, Annalee S. Boyle, Cell Reports Medicine	2021	217
Prevalence of Antibodies to Four Human Coronaviruses Is Lower in Nasal Secretions than in Serum Geoffrey J. Gorse, Gira Patel, Joseph N. Vitale, Clinical and Vaccine Immunology Nasal SecretionsDiagnostic VirologyViral DiagnosticsHcov StrainRespiratory Diseases	2010	185
Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses Yaniv Lustig, Shlomit Keler, Rachel Kolodny, Clinical Infectious Diseases	2020	178
Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests Kwok‐Hung Chan, Jasper Fuk‐Woo Chan, Herman Tse, Journal of Infection VaccinationViral DiagnosticsDiagnostic TestCovid-19 PandemicImmunology	2013	176
Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil Günther Fink, Nina Orlova-Fink, Tobias Schindler, BMJ evidence-based medicine	2020	174
Influenza immunization and COVID-19 Helena C. Maltezou, Kalliopi Theodoridou, Gregory A. Poland Vaccine VaccinationCovid-19 PandemicImmunologyInfluenza ImmunizationInfluenza Vaccine	2020	97

Page 1